Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
SynCore Biotechnology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

NT$36.8

2024-10-29

Market Capitalization

NT$1.3 B

2024-10-29

Revenue

NT$23.3 M

FY, 2024

CreditSafe Score

?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

TWDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024
Revenue7.7M13.0M13.3M6.9M15.9M20.2M23.3M
Cost of goods sold3.6M4.7M7.1M4.0M6.8M13.0K10.5M
Gross profit8.6M17.0M14.4M8.2M15.9M20.3M12.9M
Gross profit margin, %131.2%108.2%117.7%100.0%100.4%55.3%
Operating expense total257.9M371.6M345.4M409.2M160.5M46.0M52.5M
Depreciation and amortization47.2M53.2M56.5M52.4M40.1M19.7M18.2M
EBITDA(249.3M)(354.6M)(330.9M)(401.0M)(144.6M)(25.7M)(39.6M)
EBITDA margin, %-2734.6%-2481.6%-5778.8%-912.1%-127.5%-169.5%
EBIT(296.5M)(407.8M)(387.0M)(453.4M)(184.8M)(45.4M)(57.4M)
EBIT margin, %-3145.2%-2902.0%-6534.4%-1165.6%-224.8%-246.2%
Interest income2.0M1.8M1.2M1.0M1.4M2.4M2.3M
Interest expense982.0K2.0M3.4M2.0M2.3M784.0K302.0K
Pre tax profit(294.1M)(408.6M)(398.9M)(458.6M)(188.7M)(38.2M)(54.3M)
Net Income(294.1M)(408.6M)(398.9M)(458.6M)(188.7M)(38.2M)(54.3M)

Footer menu